NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia

Renata Scopim-Ribeiro, João Agostinho Machado-Neto, Christopher A. Eide, Juan Luiz Coelho-Silva, Bruna Alves Fenerich, Jaqueline Cristina Fernandes, Priscila Santos Scheucher, Samantha L. Savage Stevens, Paula de Melo Campos, Sara T. Olalla Saad, Leonardo de Carvalho Palma, Lorena Lobo de Figueiredo-Pontes, Belinda Pinto Simões, Eduardo Magalhães Rego, Cristina E. Tognon, Brian J. Druker, Fabiola Traina

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences